My Quote Request
No products added yet
6505-01-159-9251
20 Products
QUIBRON-T TABLETS
THEOPHYLLINE TABLETS,USP
NSN, MFG P/N
6505011599251
NSN
6505-01-159-9251
QUIBRON-T TABLETS
THEOPHYLLINE TABLETS,USP
NSN, MFG P/N
6505011599251
NSN
6505-01-159-9251
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE TABLETS MODIFIED 300MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC61570-0020-01
THEOPHYLLINE TABLETS,USP
NSN, MFG P/N
6505011599251
NSN
6505-01-159-9251
NDC61570-0020-01
THEOPHYLLINE TABLETS,USP
NSN, MFG P/N
6505011599251
NSN
6505-01-159-9251
MFG
MONARCH PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE TABLETS MODIFIED 300MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
QUIBRON-T
THEOPHYLLINE TABLETS,USP
NSN, MFG P/N
6505011599251
NSN
6505-01-159-9251
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE TABLETS MODIFIED 300MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00083-0016-30
METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011604201
NSN
6505-01-160-4201
NDC00083-0016-30
METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011604201
NSN
6505-01-160-4201
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS METHYLPHENIDATE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS 20MG 100S
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: VAULT STORAGE
Related Searches:
RITALIN-SR
METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011604201
NSN
6505-01-160-4201
RITALIN-SR
METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011604201
NSN
6505-01-160-4201
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS METHYLPHENIDATE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS 20MG 100S
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: VAULT STORAGE
Related Searches:
RITALIN-SR TABLETS
METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011604201
NSN
6505-01-160-4201
RITALIN-SR TABLETS
METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011604201
NSN
6505-01-160-4201
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS METHYLPHENIDATE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS 20MG 100S
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: VAULT STORAGE
Related Searches:
5015
THIOPENTAL SODIUM FOR INJECTION,USP
NSN, MFG P/N
6505011604986
NSN
6505-01-160-4986
5015
THIOPENTAL SODIUM FOR INJECTION,USP
NSN, MFG P/N
6505011604986
NSN
6505-01-160-4986
MFG
INTERNATIONAL MEDICATION SYSTEMS LTD.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS THIOPENTAL SODIUM EQUIVALENT
FEATURES PROVIDED: DILUENT AND STERILE
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE III
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: SYRINGE WITH NEEDLE
SPECIAL FEATURES: SYRINGE COMPONENTS INCLUDE 2 CAPPED AND STOPPERED VIALS; 1 VIAL CONTAINS POWDER PROVIDING 500 MILLIGRAMS OF THIOPENTAL SODIUM AND 1 VIAL CONTAINING DILUENT; 18 GAGE BY 1-1/2 INCH NEEDLE WITH LUER LOCK TIP; PROVIDES 20 MILLIMETERS OF 2.5 PERCENT THIOPENTAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: SODIUM STERILE SOLUTION
Related Searches:
NDC00548-5015-00
THIOPENTAL SODIUM FOR INJECTION,USP
NSN, MFG P/N
6505011604986
NSN
6505-01-160-4986
NDC00548-5015-00
THIOPENTAL SODIUM FOR INJECTION,USP
NSN, MFG P/N
6505011604986
NSN
6505-01-160-4986
MFG
INTERNATIONAL MEDICATION SYSTEMS LTD.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS THIOPENTAL SODIUM EQUIVALENT
FEATURES PROVIDED: DILUENT AND STERILE
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE III
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: SYRINGE WITH NEEDLE
SPECIAL FEATURES: SYRINGE COMPONENTS INCLUDE 2 CAPPED AND STOPPERED VIALS; 1 VIAL CONTAINS POWDER PROVIDING 500 MILLIGRAMS OF THIOPENTAL SODIUM AND 1 VIAL CONTAINING DILUENT; 18 GAGE BY 1-1/2 INCH NEEDLE WITH LUER LOCK TIP; PROVIDES 20 MILLIMETERS OF 2.5 PERCENT THIOPENTAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: SODIUM STERILE SOLUTION
Related Searches:
CENTRAX CAPSULES
PRAZEPAM CAPSULES,USP
NSN, MFG P/N
6505011606778
NSN
6505-01-160-6778
CENTRAX CAPSULES
PRAZEPAM CAPSULES,USP
NSN, MFG P/N
6505011606778
NSN
6505-01-160-6778
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS PRAZEPAM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE IV
Related Searches:
NDC00071-0552-30
PRAZEPAM CAPSULES,USP
NSN, MFG P/N
6505011606778
NSN
6505-01-160-6778
NDC00071-0552-30
PRAZEPAM CAPSULES,USP
NSN, MFG P/N
6505011606778
NSN
6505-01-160-6778
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS PRAZEPAM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE IV
Related Searches:
1525534
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505011607702
NSN
6505-01-160-7702
MFG
ASSOCIATION PHARMACEUTIQUE BELGE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS RANITIDINE EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE TABLETS USP 150MG 60S BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00172-4357-49
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505011607702
NSN
6505-01-160-7702
NDC00172-4357-49
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505011607702
NSN
6505-01-160-7702
MFG
TEVA PHARMACEUTICALS USA INC. DBA GATE PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS RANITIDINE EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE TABLETS USP 150MG 60S BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00173-0344-42
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505011607702
NSN
6505-01-160-7702
NDC00173-0344-42
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505011607702
NSN
6505-01-160-7702
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS RANITIDINE EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE TABLETS USP 150MG 60S BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC53746-0253-60
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505011607702
NSN
6505-01-160-7702
NDC53746-0253-60
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505011607702
NSN
6505-01-160-7702
MFG
AMNEAL PHARMACEUTICALS LLC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS RANITIDINE EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE TABLETS USP 150MG 60S BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
RANITIDINE EG 150MG X 56 COMP
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505011607702
NSN
6505-01-160-7702
RANITIDINE EG 150MG X 56 COMP
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505011607702
NSN
6505-01-160-7702
MFG
EUROGENERICS S.A.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS RANITIDINE EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE TABLETS USP 150MG 60S BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ZANTAC
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505011607702
NSN
6505-01-160-7702
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS RANITIDINE EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE TABLETS USP 150MG 60S BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ZANTAC TABLETS
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505011607702
NSN
6505-01-160-7702
ZANTAC TABLETS
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505011607702
NSN
6505-01-160-7702
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS RANITIDINE EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE TABLETS USP 150MG 60S BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ARTANE
TRIHEXYPHENIDYL HYDROCHLORIDE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011607721
NSN
6505-01-160-7721
ARTANE
TRIHEXYPHENIDYL HYDROCHLORIDE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011607721
NSN
6505-01-160-7721
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS TRIHEXYPHENIDYL HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 60.000
CAPSULE TYPE: SOFT
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,AMERICAN CYANAMID CO
Related Searches:
NDC00005-4438-32
TRIHEXYPHENIDYL HYDROCHLORIDE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011607721
NSN
6505-01-160-7721
NDC00005-4438-32
TRIHEXYPHENIDYL HYDROCHLORIDE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011607721
NSN
6505-01-160-7721
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS TRIHEXYPHENIDYL HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 60.000
CAPSULE TYPE: SOFT
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,AMERICAN CYANAMID CO
Related Searches:
NDC00068-0020-01
DESIPRAMINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011607722
NSN
6505-01-160-7722
NDC00068-0020-01
DESIPRAMINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011607722
NSN
6505-01-160-7722
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS DESIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DESIPRAMINE HYDROCHLORIDE TABLETS USP 100 MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
